Aegerion Pharmaceuticals

Aegerion Pharmaceuticals, a subsidiary of Novelion Therapeutics, is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. Headquartered in Cambridge, Massachusetts, Aegerion...
Cambridge, MA

One Main Street

Cambridge, MA, 2142
Biotechnology
http://www.novelion.com
Public Company
Rare Disease Biotech Global
2005
201 - 500
Aegerion Pharmaceuticals, a subsidiary of Novelion Therapeutics, is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. Headquartered in Cambridge, Massachusetts, Aegerion employs about 200 people in a number of countries throughout the world. For more information about the company, please visit www.novelion.com.
Not updated in last 180 days (possibly abandoned)